Tohoku University Technology: Organ Fibrosis Inhibitor: T13-204
Confirmed the effects of fibrosis and inflammation improvement in a kidney fibrosis model mouse!
When the kidneys are damaged for some reason, it is known that inflammation and fibrosis can occur. As symptoms progress, kidney failure can develop, necessitating regular dialysis. Dialysis places a significant burden on patients, and there is a desire for the development of therapeutic drugs that can delay the initiation of dialysis. The inventors have discovered compounds with anti-inflammatory and anti-fibrotic effects. The group of compounds in this invention is expected to be utilized as fibrosis inhibitors.
- Company：Tohoku Techno Arch Co., Ltd.
- Price：Other
